miR-34a is a tumor suppressor in zebrafish and its expression levels impact metabolism, hematopoiesis and DNA damage
Sergey V. Prykhozhij,Kevin Ban,Zane L. Brown,Kim Kobar,Gabriel Wajnberg,Charlotte Fuller,Simi Chacko,Jacynthe Lacroix,Nicolas Crapoulet,Craig Midgen,Adam Shlien,David Malkin,Jason N. Berman
DOI: https://doi.org/10.1371/journal.pgen.1011290
IF: 4.5
2024-05-29
PLoS Genetics
Abstract:Li-Fraumeni syndrome is caused by inherited TP53 tumor suppressor gene mutations. MicroRNA miR-34a is a p53 target and modifier gene. Interestingly, miR-34 triple-null mice exhibit normal p53 responses and no overt cancer development, but the lack of miR-34 promotes tumorigenesis in cancer-susceptible backgrounds. miR-34 genes are highly conserved and syntenic between zebrafish and humans. Zebrafish miR-34a and miR-34b / c have similar expression timing in development, but miR-34a is more abundant. DNA damage by camptothecin led to p53-dependent induction of miR-34 genes, while miR-34a mutants were adult-viable and had normal DNA damage-induced apoptosis. Nevertheless, miR-34a -/- compound mutants with a gain-of-function tp53 R217H/ R217H or tp53-/- mutants were more cancer-prone than tp53 mutants alone, confirming the tumor-suppressive function of miR-34a . Through transcriptomic comparisons at 28 hours post-fertilization (hpf), we characterized DNA damage-induced transcription, and at 8, 28 and 72 hpf we determined potential miR-34a-regulated genes. At 72 hpf, loss of miR- 34a enhanced erythrocyte levels and up-regulated myb -positive hematopoietic stem cells. Overexpression of miR-34a suppressed its reporter mRNA, but not p53 target induction, and sensitized injected embryos to camptothecin but not to γ-irradiation. Li-Fraumeni syndrome, rooted in inherited mutations of the TP53 tumor suppressor gene, presents a complex interplay with microRNA34a ( miR-34a ), a known p53 target and modifier gene. Notably, miR-34 triple-null mice, despite exhibiting typical p53 responses and no evident cancer development, unveil a crucial role for miR-34 genes in suppressing tumorigenesis, particularly in predisposed conditions. The evolutionary conservation of miR-34 genes across zebrafish and humans underscores their significance. Studying zebrafish embryos reveals intriguing insights into miR-34a dynamics during development and its response to DNA damage, illuminating its involvement in cancer susceptibility. Additionally, experiments involving miR-34a mutants further confirm its tumor-suppressive function, especially when coupled with tp53 mutations. Transcriptomic analysis at different developmental stages uncover potential genes regulated by miR-34a, shedding light on its broader regulatory role. These findings enhance our understanding of the intricate mechanisms underlying cancer susceptibility and highlight miR-34a as a potential therapeutic target for Li-Fraumeni syndrome and related malignancies.
genetics & heredity